Pandion Therapeutics

YTD

ALL

Why Robinhood?

You can watch PAND and buy or sell other stocks, ETFs, and their options commission-free!

About PAND

Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network.

CEO

Rahul Kakkar, MD

CEORahul Kakkar, MD

Employees

—

Employees—

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2016

Founded2016

Employees

—

Employees—

PAND Key Statistics

Market cap

1.77B

Market cap1.77B

Price-Earnings ratio

-39.69

Price-Earnings ratio-39.69

Dividend yield

—

Dividend yield—

Average volume

313.84K

Average volume313.84K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$62.90

52 Week high$62.90

52 Week low

$10.28

52 Week low$10.28

People also own

Based on the portfolios of people who own PAND. This list is generated using Robinhood data, and it’s not a recommendation.

Virgin Galactic Holdings